Search Results for: C1QBP

Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
PRKCZ protein kinase C zeta
  • GPVI-mediated activation cascade
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • VEGFR2 mediated cell proliferation
  • RHO GTPases Activate NADPH Oxidases
  • Estrogen-stimulated signaling through PRKCZ
  • Estrogen-stimulated signaling through PRKCZ
  • Tamoxifen
  • Staurosporine
  • Dequalinium
  • Benzoyl peroxide
PRKD1 protein kinase D1
  • Sphingolipid de novo biosynthesis
  • Bryostatin 1
  • Fostamatinib
PRRC2A proline rich coiled-coil 2A
SHANK3 SH3 and multiple ankyrin repeat domains 3
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • RET signaling
SRSF1 serine and arginine rich splicing factor 1
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • mRNA 3'-end processing
  • Processing of Capped Intron-Containing Pre-mRNA
  • RNA Polymerase II Transcription Termination
  • Copper
SRSF9 serine and arginine rich splicing factor 9
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • mRNA Splicing - Major Pathway
  • mRNA 3'-end processing
  • Processing of Capped Intron-Containing Pre-mRNA
  • RNA Polymerase II Transcription Termination
TOP3B DNA topoisomerase III beta
ULK1 unc-51 like autophagy activating kinase 1
  • Macroautophagy
  • Regulation of TNFR1 signaling
  • TBC/RABGAPs
  • RAB GEFs exchange GTP for GDP on RABs
  • Receptor Mediated Mitophagy
  • Fostamatinib
YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • MTOR signalling
  • mTORC1-mediated signalling
  • Frs2-mediated activation
  • Frs2-mediated activation
  • ARMS-mediated activation
  • Signaling by Hippo
  • Rap1 signalling
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • RAF activation
  • MAP2K and MAPK activation
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Regulation of localization of FOXO transcription factors
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • SHOC2 M1731 mutant abolishes MRAS complex function
  • Gain-of-function MRAS complexes activate RAF signaling
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Copper
  • Phenethyl Isothiocyanate
YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • AURKA Activation by TPX2
  • Regulation of localization of FOXO transcription factors
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • SPOP-mediated proteasomal degradation of PD-L1(CD274)

Page 6 out of 6 pages